Pingyangmycin stimulates apoptosis in human hemangioma-derived endothelial cells through activation of the p53 pathway

Molecular Medicine Reports

Volumn 10, Issue 1, 2014, Pages 301-305

  Tu, Jun Bo ^a   Li, Quan Yan ^a   Jiang, Fei ^a   Hu, Xiao Yi ^a   Ma, Rui Zhao ^a   Dong, Qiang ^b   Zhang, Hao ^a   Pattar, Parukjan ^a   Li, Shi Xian ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Stomatological Hospital   (China)

Author keywords

Apoptosis; Gene expression profiling; Hemangioma; p53 pathway; Tumor

Indexed keywords

BLEOMYCIN A5; COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN MDM2; PROTEIN P53; PUMA PROTEIN; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; PROTEIN BAX;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CAPILLARY HEMANGIOMA; CELL MEMBRANE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MORPHOLOGICAL TRAIT; POLYMERASE CHAIN REACTION; PROTEIN ACTIVATION; PROTEIN FUNCTION; REGULATORY MECHANISM; THERAPY EFFECT; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANALOGS AND DERIVATIVES; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; GENETICS; HEMANGIOMA; METABOLISM; PATHOLOGY; TOXICITY; TUMOR CELL CULTURE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLEOMYCIN; DOWN-REGULATION; ENDOTHELIAL CELLS; HEMANGIOMA; HUMANS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84901430339     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2174     Document Type: Article

References (30)

1. Mendiratta V and Jabeen M: Infantile hemangioma: an update. Indian J Dermatol Venereol Leprol 76: 469-475, 2010.
2. Kwon EK, Seefeldt M and Drolet BA: Infantile hemangiomas: an update. Am J Clin Dermatol 14: 111-123, 2013.
3. Eivazi B and Werner JA: Management of vascular malformations and hemangiomas of the head and neck - an update. Curr Opin Otolaryngol Head Neck Surg 21: 157-163, 2013.
4. Itinteang T, Withers AH, Leadbitter P, et al: Pharmacologic therapies for infantile hemangioma: is there a rational basis? Plast Reconstr Surg 128: 499-507, 2011.
5. Bischoff J: Monoclonal expansion of endothelial cells in hemangioma: an intrinsic defect with extrinsic consequences? Trends Cardiovasc Med 12: 220-224, 2002.
6. Peng Q, Liu W, Zhou F, et al: An experimental study on the therapy of infantile hemangioma with recombinant interferon γ. Pediatr Surg 46: 496-501, 2011.
7. Storch CH and Hoeger PH: Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163: 269-274, 2010.
8. Ouyang L, Shi Z, Zhao S, et al: Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 45: 487-498, 2012.
9. Haupt S, Berger M, Goldberg Z and Haupt Y: Apoptosis - the p53 network. J Cell Sci 116: 4077-4085, 2003. (Pubitemid 37337082)
10. Dai F, Chen Y, Song Y, et al: A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. PLoS One 7: e52162, 2012.
11. Ji Y, Li K, Xiao X, et al: Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells. J Pediatr Surg 47: 2216-2223, 2012.
12. Chen P, Liu B and Hu M: The effect of hydroxycamptothecin and pingyangmycin on human squamous cell carcinoma of the tongue. Oncol Lett 5: 947-952, 2013.
13. Gong JH, Liu XJ, Li Y and Zhen YS: Pingyangmycin down-regulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice. Cancer Chemother Pharmacol 69: 1323-1332, 2012.
14. Hou J, Wang M, Tang H, et al: Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients. Int J Oral Maxillofac Surg 40: 1246-1251, 2011.
15. Luo QF and Zhao FY: The effects of Bleomycin A5 on infantile maxillofacial haemangioma. Head Face Med 7: 11, 2011.
16. Tu JB, Dong Q, Hu XY, et al: Proteomic analysis of mitochondria from infantile hemangioma endothelial cells treated with sodium morrhuate and its liposomal formulation. J Biochem Mol Toxicol 26: 374-380, 2012.
17. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
18. Guan JY, He XF, Chen Y, et al: Percutaneous intratumoral injection with pingyangmycin lipiodol emulsion for the treatment of recurrent sacrococcygeal chordomas. J Vasc Interv Radiol 22: 1216-1220, 2011.
19. Ho YC, Tai KW and Chang YC: Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells. Oral Dis 13: 40-44, 2007.
20. Sgonc R, Fuerhapter C, Boeck G, et al: Induction of apoptosis in human dermal microvascular endothelial cells and infantile hemangiomas by interferon-alpha. Int Arch Allergy Immunol 117: 209-214, 1998. (Pubitemid 28526169)
21. Sethi G, Shanmugam MK, Ramachandran L, et al: Multifaceted link between cancer and inflammation. Biosci Rep 32: 1-15, 2012.
22. Lindgren T, Stigbrand T, Riklund K, et al: Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis. Tumour Biol 33: 689-700, 2012.
23. Di J, Zhang Y and Zheng J: Reactivation of p53 by inhibiting Mdm2 E3 ligase: a novel antitumor approach. Curr Cancer Drug Targets 11: 987-994, 2011.
24. Bradley G, Tremblay S, Irish J, et al: The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma. Br J Cancer 96: 1425-1432, 2007. (Pubitemid 46685800)
25. Nakano K and Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694, 2001. (Pubitemid 32706359)
26. Nicholls CD, Shields MA, Lee PW, et al: UV-dependent alternative splicing uncouples p53 activity and PIG3 gene function through rapid proteolytic degradation. J Biol Chem 279: 24171-24178, 2004. (Pubitemid 38725277)
27. Lee JH, Kang Y, Khare V, et al: The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene 29: 1431-1450, 2010.
28. Thornborrow EC, Patel S, Mastropietro AE, et al: A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 21: 990-999, 2002. (Pubitemid 34174511)
29. Haupt S, Berger M, Goldberg Z and Haupt Y: Apoptosis - the p53 network. J Cell Sci 116: 4077-4085, 2003. (Pubitemid 37337082)
30. Yang H, Deng C, Shen S, et al: Expression and significance of Bcl-2, Bax, Fas and caspase-3 in different phases of human hemangioma. J Huazhong Univ Sci Technolog Med Sci 26: 402-404, 2006.